Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study is evaluating cefiderocol clearance in patients with acute burn injuries; recruitment is ongoing under the University of Tenness…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefiderocol (cefiderocol)

Snippet

Sponsor: University of Tennessee | Conditions: Drug Clearance After Severe Burn Injury | Phase 4 | Status: RECRUITING